PET scan study of immune activity after COVID-19
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This Phase 2 study uses a special PET scan to look at how active your immune system is after a recent COVID-19 infection. The goal is to understand what the immune response looks like and whether this imaging approach could help guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old and can read and understand the consent form
- You had a recent COVID-19 infection confirmed by a positive lab test from a nose/throat or breathing sample
- More than 14 days have passed since your COVID symptoms started (or since your test if you had no symptoms)
- Blood test results must be within required ranges (platelets, white blood cells, liver enzymes, and kidney function)
- You must be able to have the PET imaging done safely (your doctor/investigator agrees it won’t be compromised)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.
This Phase 2 study uses a special whole-body scan (PET-MR) to measure immune activity in people living with HIV. It may help researchers understand how well the immune system responds and how to better track HIV-related inflammation.
This study uses a single injection and a special type of PET scan to look at how your body's tissues use fuel (metabolism). It helps researchers learn more about normal and disease-related changes in the heart, liver, and other organs.
This early-phase study uses a special PET scan to look for signs of brain inflammation in people with ongoing (long-term) nervous system symptoms after COVID-19. It may help researchers understand what is driving symptoms and whether this imaging approach can detect inflammation.
This Phase 1 study uses a PET scan to detect blood clots (thrombosis) in specific groups of people. It’s testing how well the scan can find clots and how it should be timed with other heart or illness tests.
This trial uses a special PET scan tracer to see where immune system signals are active in people with cancer. It may help doctors understand how your immune system is responding to the disease.
Hear when a new Covid19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.